HARBOUR INVESTMENTS, INC. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
HARBOUR INVESTMENTS, INC. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$24,845
-3.5%
1,606
-2.0%
0.00%0.0%
Q2 2023$25,749
+265.1%
1,639
+282.9%
0.00%
Q1 2023$7,053
-9.2%
428
-14.1%
0.00%
Q4 2022$7,769
+11.0%
4980.0%0.00%
Q3 2022$7,0000.0%4980.0%0.00%
Q2 2022$7,000
+16.7%
498
+17.5%
0.00%
Q4 2021$6,000
-91.8%
424
-90.5%
0.00%
-100.0%
Q3 2021$73,000
-6.4%
4,440
-4.6%
0.00%0.0%
Q2 2021$78,000
-3.7%
4,652
+4.8%
0.00%
-33.3%
Q1 2021$81,0004,4400.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 30,201$3,149,00019.29%
MANAGED ASSET PORTFOLIOS, LLC 1,399,878$20,046,0002.75%
Clean Yield Group 251,220$3,597,0001.27%
Mondrian Investment Partners LTD 4,319,715$60,476,0001.24%
Sippican Capital Advisors 80,490$1,153,0000.96%
TFG Asset Management GP Ltd 1,275,656$18,268,0000.83%
Lumbard & Kellner, LLC 132,516$1,898,0000.74%
BRANDES INVESTMENT PARTNERS, LP 2,109,846$30,213,0000.65%
CAUSEWAY CAPITAL MANAGEMENT LLC 1,601,046$22,927,0000.55%
Ridgewood Investments LLC 33,378$478,0000.31%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders